Back to Search
Start Over
CO14 Patient-Reported Outcomes (PROS) With Ramucirumab Versus Placebo in Chinese Patients With Hepatocellular Carcinoma (HCC) and Elevated Alpha-Fetoprotein From the Randomized Phase 3 Reach-2 Study.
- Source :
-
Value in Health . 2022 Suppl, Vol. 25 Issue 12, pS19-S20. 2p. - Publication Year :
- 2022
- Subjects :
- *CHINESE people
*HEPATOCELLULAR carcinoma
*ALPHA fetoproteins
*PLACEBOS
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 25
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 160758550
- Full Text :
- https://doi.org/10.1016/j.jval.2022.09.095